After NuVision Pharmacy refused FDA’s most recent request (PDF) to recall all of its sterile products, FDA is reminding health care providers not to use NuVision sterile products. This reminder is an update to a May 18, 2013 notice recommending health care providers quarantine all NuVision sterile products, and stop giving them to patients. In April 2013, NuVision recalled methylcobalamin injection and lyophilized injection products citing concerns about sterility in the wake of adverse event reports of “fever, flu-like symptoms, and soreness of the injection site” associated with the methylcobalamin injection product. FDA reports that it is not aware of adverse events related to any other NuVision products, but continues to pursue a recall of all sterile products produced by the company in order to ensure the safety of public health.